Cargando…

Anti-miR delivery strategies to bypass the blood-brain barrier in glioblastoma therapy

Small non-coding RNAs called miRNAs are key regulators in various biological processes, including tumor initiation, propagation, and metastasis in glioblastoma as well as other cancers. Recent studies have shown the potential for oncogenic miRNAs as therapeutic targets in glioblastoma. However, the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Dong Geon, Kim, Kang Ho, Seo, Yun Jee, Yang, Heekyoung, Marcusson, Eric G., Son, Eunju, Lee, Kyoungmin, Sa, Jason K., Lee, Hye Won, Nam, Do-Hyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045404/ https://www.ncbi.nlm.nih.gov/pubmed/27102443 http://dx.doi.org/10.18632/oncotarget.8837

Ejemplares similares

Therapeutic Efficacy of GC1118, a Novel Anti-EGFR Antibody, against Glioblastoma with High EGFR Amplification in Patient-Derived Xenografts
por: Lee, Kyoungmin, et al.
Publicado: (2020)

Promising Therapeutic Efficacy of GC1118, an Anti-EGFR Antibody, against KRAS Mutation-Driven Colorectal Cancer Patient-Derived Xenografts
por: Lee, Hye Won, et al.
Publicado: (2019)

Anti-SEMA3A Antibody: A Novel Therapeutic Agent to Suppress Glioblastoma Tumor Growth
por: Lee, Jaehyun, et al.
Publicado: (2018)

Autistic-like social deficits in hippocampal MeCP2 knockdown rat models are rescued by ketamine
por: Choi, Miyeon, et al.
Publicado: (2022)

Novel Semi-Replicative Retroviral Vector Mediated Double Suicide Gene Transfer Enhances Antitumor Effects in Patient-Derived Glioblastoma Models
por: Lee, Mijeong, et al.
Publicado: (2019)

Synthesis and biological evaluation of potent benzoselenophene and heteroaromatic analogues of (S)-1-(chloromethyl)-8-methoxy-2,3-dihydro-1H-benzo[e]indol-5-ol (seco-MCBI)
por: Mhetre, Amol B., et al.
Publicado: (2019)

Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma
por: Nam, Yoonhee, et al.
Publicado: (2023)

Overcoming delivery barriers in immunotherapy for glioblastoma
por: Rui, Yuan, et al.
Publicado: (2021)

FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2
por: Lee, Yeri, et al.
Publicado: (2015)

Nanotherapeutics for Nose-to-Brain Drug Delivery: An Approach to Bypass the Blood Brain Barrier
por: Lee, David, et al.
Publicado: (2021)

KML001, a Telomere-Targeting Drug, Sensitizes Glioblastoma Cells to Temozolomide Chemotherapy and Radiotherapy through DNA Damage and Apoptosis
por: Woo, Seon Rang, et al.
Publicado: (2014)

Mutation-specific non-canonical pathway of PTEN as a distinct therapeutic target for glioblastoma
por: Choi, Seung Won, et al.
Publicado: (2021)

Editorial: Bypassing the Biological Barriers by Means of Biocompatible Drug Delivery Systems
por: Awasthi, Vibhudutta, et al.
Publicado: (2021)

Bypassing the Blood–Brain Barrier: Direct Intracranial Drug Delivery in Epilepsies
por: Gernert, Manuela, et al.
Publicado: (2020)

Delivery across the blood-brain barrier: nanomedicine for glioblastoma multiforme
por: Jena, Lynn, et al.
Publicado: (2019)

Breaking barriers for glioblastoma with a path to enhanced drug delivery
por: Noorani, Imran, et al.
Publicado: (2023)

Understanding Glioblastoma Signaling, Heterogeneity, Invasiveness, and Drug Delivery Barriers
por: Rabah, Nadin, et al.
Publicado: (2023)

Translational Validation of Personalized Treatment Strategy Based on Genetic Characteristics of Glioblastoma
por: Oh, Young Taek, et al.
Publicado: (2014)

Immunohistochemical Classification of Primary and Secondary Glioblastomas
por: Lee, Kyu Sang, et al.
Publicado: (2013)

Endotracheal tube fire during tracheostomy
por: Lee, Eunju, et al.
Publicado: (2012)

Ethnic delineation of primary glioblastoma genome
por: Koo, Harim, et al.
Publicado: (2020)

Normal Adult Hippocampal Neurogenesis in SRG3-overexpressing Transgenic Mice
por: Kim, Byungwoo, et al.
Publicado: (2010)

PIP4K2A as a negative regulator of PI3K in PTEN-deficient glioblastoma
por: Shin, Yong Jae, et al.
Publicado: (2019)

Anticancer activity of TTAC-0001, a fully human anti-vascular endothelial growth factor receptor 2 (VEGFR-2/KDR) monoclonal antibody, is associated with inhibition of tumor angiogenesis
por: Kim, Dong Geon, et al.
Publicado: (2015)

Predictive value of rotational thromboelastometry during cardiopulmonary bypass for thrombocytopenia and hypofibrinogenemia after weaning of cardiopulmonary bypass
por: Ji, Sung-Mi, et al.
Publicado: (2015)

Integrative radiogenomic analysis for genomic signatures in glioblastomas presenting leptomeningeal dissemination
por: You, Hye Jin, et al.
Publicado: (2016)

Exosomes: Promising Delivery Tools for Overcoming Blood-Brain Barrier and Glioblastoma Therapy
por: Khatami, Seyyed Hossein, et al.
Publicado: (2023)

In vivo RNAi screen identifies NLK as a negative regulator of mesenchymal activity in glioblastoma
por: Sa, Jason K., et al.
Publicado: (2015)

Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma
por: Sa, Jason K., et al.
Publicado: (2020)

Intraosseous administration into the skull: Potential blood–brain barrier bypassing route for brain drug delivery
por: Kang, Ji Hee, et al.
Publicado: (2022)

ARS2/MAGL signaling in glioblastoma stem cells promotes self-renewal and M2-like polarization of tumor-associated macrophages
por: Yin, Jinlong, et al.
Publicado: (2020)

Synergy of circulating miR-212 with markers for cardiovascular risks to enhance estimation of atherosclerosis presence
por: Jeong, Hye Seon, et al.
Publicado: (2017)

Relevance of a TCGA-derived Glioblastoma Subtype Gene-Classifier among Patient Populations
por: Teo, Wan-Yee, et al.
Publicado: (2019)

Quantitative radiomic profiling of glioblastoma represents transcriptomic expression
por: Kong, Doo-Sik, et al.
Publicado: (2018)

NTRK1 Fusion in Glioblastoma Multiforme
por: Kim, Jinkuk, et al.
Publicado: (2014)

Azathioprine antagonizes aberrantly elevated lipid metabolism and induces apoptosis in glioblastoma
por: Nam, Hye Jin, et al.
Publicado: (2021)

Bypassing reproductive barriers by chemical epimutagenesis
por: Bischof, Sylvain
Publicado: (2022)

Nanocell-mediated delivery of miR-34a counteracts temozolomide resistance in glioblastoma
por: Khan, Muhammad Babar, et al.
Publicado: (2021)

Restoration of miR-29b exerts anti-cancer effects on glioblastoma
por: Shin, Jaekyung, et al.
Publicado: (2017)

Targeted Delivery of Exosomes Armed with Anti-Cancer Therapeutics
por: Choi, Hojun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_72bm1oilsrj6p83nk625nv9fe9